All News Biomark Diagnostics Inc.

Equities

20B

CA09073K1084

Delayed Deutsche Boerse AG Other stock markets 05:29:33 2024-07-12 am EDT			5-day change	1st Jan Change
0.124 ^EUR	-8.15%		-13.89%	-15.65%

Feb. 29	Biomark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
Feb. 28	BioMark Diagnostics Inc. Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Biomark Diagnostics : Announces Warrant Extension and Granting of Options	May. 06	PU
BioMark Announces Warrant Extension and Granting of Options	Apr. 18	NE
BioMark to Advance Development of Cancer Treatment for Glioblastoma	Apr. 09	NE
Biomark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 29	CI
BioMark Diagnostics Inc. Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities	Feb. 28	CI
BioMark Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities	Feb. 28	NE
Biomark Diagnostics Inc. Appoints Theresa Peterson as Member of Advisory Team	Feb. 26	CI
Theresa Peterson Joins Biomark's Advisory Team	Feb. 26	NE
Biomark Diagnostics Closes $1.9 Million Non-Brokered Private Placement	Dec. 29	MT
BioMark Announces Closing of $1.9 Million Non-Brokered Private Placement	Dec. 29	NE
Biomark Diagnostics Inc. announced that it has received CAD 1.9 million in funding	Dec. 28	CI
BioMark Announces New Patent Granted in Canada For Liquid Biopsy Based Legacy Assay	Dec. 04	MT
BioMark Announces Recent New Patent Granted in Canada to Support Its Liquid Biopsy Based Legacy Assay	Dec. 04	NE
BioMark Provides Second Quarter Operational Update and Announces Extension to Warrant Exercise Term	Nov. 28	NE
Biomark Diagnostics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 28	CI
BioMark Diagnostics Inc. Appoints Randolph Ford to its Strategic Advisory Team	Nov. 14	CI
BioMark Strengthens and Expands Its Strategic Advisory Team in Pursuit of Commercialization Initiatives	Nov. 14	NE
BioMark Announces Financial Contribution from the City of Quebec to Support Commercialization Initiatives of Its Proprietary Lung Cancer Detection Test	Nov. 07	NE
BioMark to Unveil Results of Its Early Breast Cancer Study at the Upcoming San Antonio Breast Cancer Symposium	23-10-24	NE
Biomark Diagnostics : Une Technologie d’ici Pour Mieux Diagnostiquer le Cancer du Poumon – Local Technology for Improved Lung Cancer Diagnosis	23-09-10	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Biomark Diagnostics Inc.

Equities

20B

CA09073K1084

All News

Filters